Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone Implant vs Anti-VEGF for Persistent DME
NCT02471651Phase 4Completed
- Sponsor
- California Retina Consultants
- Start
- Jun 2015
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexamethasone in diabetic macular edema (DME) (2 arms), sponsored by California Retina Consultants. Primary endpoint: Mean Change in Central 1 mm Subfield Thickness at 9 months. Started Jun 2015; status: completed.
02
Drugs
dexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02471651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02471651.